Notably, PD-L1 CPS accounts for both PD-L1 positive tumor cells and immune cells and seems highly reproducible in gastric cancer with higher CPS indicating increased likelihood of responding to pembrolizumab [66]. This evidence concerns the gene CD274 and gastric cancer.